No Data
No Data
Stifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Ratings for Zymeworks (NASDAQ:ZYME) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of their recent r
Express News | HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $10 Price Target
Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup
Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup
Zymeworks Is Maintained at Overweight by Wells Fargo
Zymeworks Is Maintained at Overweight by Wells Fargo
Express News | Wells Fargo Maintains Overweight on Zymeworks, Lowers Price Target to $12